{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:48:04Z","timestamp":1790920084269,"version":"4.1.0"},"posted":{"date-parts":[[2025,2,3]]},"group-title":"Microbiology","reference-count":48,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Bacteriophages are increasingly explored as antibacterial agents for therapeutic applications and pathogen biocontrol. Rigorous quality control and removal of microbial growth byproducts is essential for safety and compliance with regulatory standards for the use of phages; for phages isolated from Gram-negative bacterial lysates, this involves removal of endotoxin (lipopolysaccharide\/LPS) and contaminating host proteins. Here, we describe the development of CIMmultus OH-Monolithic chromatography as a single-step purification process for five tailed anti-pseudomonal phages, including myoviral and siphoviral morphologies, as well as so-called \u201cjumbo\u201d phages, yielding therapeutically compliant samples suitable for human IV administration. Using preferential exclusion chromatography with a potassium phosphate gradient, we achieved near-complete removal of endotoxin (99.96-100.00% depletion) and protein impurities (95.8-99.7% depletion). We found that phage recovery post-purification was inversely associated with tail length and hydrodynamic diameter, with shorter-tailed and smaller phages demonstrating greater recovery. We conclude that single-step CIMmultus OH-monolithic chromatography is scalable, reproducible, and free from hazardous chemicals, supporting its integration into industrial phage purification processes.<\/jats:p>","DOI":"10.1101\/2025.02.03.636326","type":"posted-content","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:50:19Z","timestamp":1738619419000},"source":"Crossref","is-referenced-by-count":4,"title":["Single-step monolithic chromatography efficiently purifies diverse Pseudomonas aeruginosa phages with therapeutic-grade endotoxin reduction"],"prefix":"10.64898","author":[{"given":"Arne","family":"Echterhof","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"},{"name":"Institute of Medical Microbiology, University Hospital of Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Dharmaraj","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blankenberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hajfathalian","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Blankenberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Sacher","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Bollyky","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026041023375454000_2025.02.03.636326v2.1","doi-asserted-by":"crossref","unstructured":"Chen, Q. et al. Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics. Pharmaceutics 14, (2022).","DOI":"10.3390\/pharmaceutics14071425"},{"key":"2026041023375454000_2025.02.03.636326v2.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1934.72750490003007"},{"key":"2026041023375454000_2025.02.03.636326v2.3","first-page":"329","article-title":"Bacteriophage as a Treatment in Acute Medical and Surgical Infections","volume":"7","year":"1931","journal-title":"Bull. N. Y. Acad. Med"},{"key":"2026041023375454000_2025.02.03.636326v2.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00649-x"},{"key":"2026041023375454000_2025.02.03.636326v2.5","unstructured":"Organisation, W. H. 2021 Antibacterial Agents in Clinical and Preclinical Development: an overview and analysis. World Health Organization 2021 https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (2022)."},{"key":"2026041023375454000_2025.02.03.636326v2.6","doi-asserted-by":"publisher","DOI":"10.1007\/S00408-024-00700-7"},{"key":"2026041023375454000_2025.02.03.636326v2.7","doi-asserted-by":"crossref","unstructured":"Aslam, S. et al. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infect. Dis. 7, (2020).","DOI":"10.1093\/ofid\/ofaa389"},{"key":"2026041023375454000_2025.02.03.636326v2.8","first-page":"1434","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","year":"2024","journal-title":"Nature Microbiology 2024 9:6"},{"key":"2026041023375454000_2025.02.03.636326v2.9","unstructured":"CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) ClinicalTrials.gov identifier: NCT04684641 . Updated 2023-11-18. Accessed October 15, 2024. ."},{"key":"2026041023375454000_2025.02.03.636326v2.10","unstructured":"Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection. ClinicalTrials.gov identifier: NCT05010577 . Updated 2023-10-18. Accessed October 15, 2024."},{"key":"2026041023375454000_2025.02.03.636326v2.11","doi-asserted-by":"crossref","unstructured":"Villalpando-Aguilar, J. L. , Matos-Pech, G. , L\u00f3pez-Rosas, I. , Castel\u00e1n-S\u00e1nchez, H. G. & Alatorre-Cobos, F. Phage Therapy for Crops: Concepts, Experimental and Bioinformatics Approaches to Direct Its Application. Int. J. Mol. Sci. 24, (2022).","DOI":"10.3390\/ijms24010325"},{"key":"2026041023375454000_2025.02.03.636326v2.12","doi-asserted-by":"publisher","DOI":"10.1021\/acssynbio.5b00296"},{"key":"2026041023375454000_2025.02.03.636326v2.13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.chembiol.2022.06.003","article-title":"Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria","volume":"29","year":"2022","journal-title":"Cell Chem. Biol"},{"key":"2026041023375454000_2025.02.03.636326v2.14","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acssynbio.2c00244","article-title":"SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies","volume":"11","year":"2022","journal-title":"ACS Synth. Biol"},{"key":"2026041023375454000_2025.02.03.636326v2.15","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/acssynbio.3c00239","article-title":"Cell Free Bacteriophage Synthesis from Engineered Strains Improves Yield","volume":"12","year":"2023","journal-title":"ACS Synth. Biol"},{"key":"2026041023375454000_2025.02.03.636326v2.16","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.06.636931"},{"key":"2026041023375454000_2025.02.03.636326v2.17","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.07.593005"},{"key":"2026041023375454000_2025.02.03.636326v2.18","doi-asserted-by":"crossref","first-page":"1250339","DOI":"10.3389\/fcimb.2023.1250339","article-title":"Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection","volume":"13","year":"2023","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"2026041023375454000_2025.02.03.636326v2.19","doi-asserted-by":"crossref","unstructured":"Dharmaraj, T. et al. Rapid assessment of changes in phage bioactivity using dynamic light scattering. PNAS nexus 2, (2023).","DOI":"10.1093\/pnasnexus\/pgad406"},{"key":"2026041023375454000_2025.02.03.636326v2.20","first-page":"1","article-title":"A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections","volume":"15","year":"2024","journal-title":"Nature Communications 2024 15:1"},{"key":"2026041023375454000_2025.02.03.636326v2.21","doi-asserted-by":"crossref","unstructured":"Echterhof, A. et al. The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo. JCI Insight 9, (2024).","DOI":"10.1172\/jci.insight.181309"},{"key":"2026041023375454000_2025.02.03.636326v2.22","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ADM8470\/SUPPL_FILE\/SCIADV.ADM8470_SM.PDF"},{"key":"2026041023375454000_2025.02.03.636326v2.23","doi-asserted-by":"crossref","unstructured":"Burgener, E. B. et al. The lysogenic filamentous Pseudomonas bacteriophage phage Pf slows mucociliary transport. PNAS Nexus 3, (2024).","DOI":"10.1093\/pnasnexus\/pgae390"},{"key":"2026041023375454000_2025.02.03.636326v2.24","doi-asserted-by":"crossref","unstructured":"Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science (1979). 363, (2019).","DOI":"10.1126\/science.aat9691"},{"key":"2026041023375454000_2025.02.03.636326v2.25","doi-asserted-by":"crossref","unstructured":"Chaiwut, R. & Kasinrerk, W. Very low concentration of lipopolysaccharide can induce the production of various cytokines and chemokines in human primary monocytes. BMC Res. Notes 15, (2022).","DOI":"10.1186\/s13104-022-05941-4"},{"key":"2026041023375454000_2025.02.03.636326v2.26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.583518"},{"key":"2026041023375454000_2025.02.03.636326v2.27","first-page":"1","article-title":"Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers","volume":"11","year":"2014","journal-title":"Journal of Inflammation (United Kingdom)"},{"key":"2026041023375454000_2025.02.03.636326v2.28","first-page":"16185","article-title":"Endotoxic Septic Shock: Diagnosis and Treatment","volume":"24","year":"2023","journal-title":"International Journal of Molecular Sciences 2023, Vol. 24, Page 16185"},{"key":"2026041023375454000_2025.02.03.636326v2.29","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.febslet.2015.06.045","article-title":"LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNF\u03b1-converting enzyme","volume":"589","year":"2015","journal-title":"FEBS Lett"},{"key":"2026041023375454000_2025.02.03.636326v2.30","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-41986-2_25"},{"key":"2026041023375454000_2025.02.03.636326v2.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2018.03.021"},{"key":"2026041023375454000_2025.02.03.636326v2.32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00216-021-03648-2","article-title":"Monitoring process-related impurities in biologics\u2013host cell protein analysis","volume":"414","year":"2022","journal-title":"Anal. Bioanal. Chem"},{"key":"2026041023375454000_2025.02.03.636326v2.33","doi-asserted-by":"publisher","DOI":"10.1002\/bit.25647"},{"key":"2026041023375454000_2025.02.03.636326v2.34","doi-asserted-by":"crossref","first-page":"465890","DOI":"10.1016\/j.chroma.2025.465890","article-title":"Scalable purification of bacteriophages preparations","volume":"1749","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"2026041023375454000_2025.02.03.636326v2.35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2013.02.004","article-title":"Fast separation of large biomolecules using short monolithic columns","volume":"927","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci"},{"key":"2026041023375454000_2025.02.03.636326v2.36","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/elps.202200270","article-title":"Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography","volume":"44","year":"2023","journal-title":"Electrophoresis"},{"key":"2026041023375454000_2025.02.03.636326v2.37","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200500246"},{"key":"2026041023375454000_2025.02.03.636326v2.38","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHROMA.2012.10.062"},{"key":"2026041023375454000_2025.02.03.636326v2.39","doi-asserted-by":"crossref","unstructured":"Rebula, L. , Raspor, A. , Bav\u010dar, M. , \u0160 trancar, A. & Leskovec, M. CIM monolithic chromatography as a useful tool for endotoxin reduction and purification of bacteriophage particles supported with PAT analytics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1217, (2023).","DOI":"10.1016\/j.jchromb.2023.123606"},{"key":"2026041023375454000_2025.02.03.636326v2.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2004.06.012"},{"key":"2026041023375454000_2025.02.03.636326v2.41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-0248(88)90296-5","article-title":"Mechanism of protein precipitation and stabilization by co-solvents","volume":"90","year":"1988","journal-title":"J. Cryst. Growth"},{"key":"2026041023375454000_2025.02.03.636326v2.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.05.048"},{"key":"2026041023375454000_2025.02.03.636326v2.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.09.018.CIM"},{"key":"2026041023375454000_2025.02.03.636326v2.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2016.11.020"},{"key":"2026041023375454000_2025.02.03.636326v2.45","doi-asserted-by":"crossref","unstructured":"Guan, J. & Bondy-Denomy, J. Intracellular Organization by Jumbo Bacteriophages. J. Bacteriol. 203, (2020).","DOI":"10.1128\/JB.00362-20"},{"key":"2026041023375454000_2025.02.03.636326v2.46","first-page":"1956","article-title":"Bacteriophage genome engineering with CRISPR\u2013Cas13a","volume":"7","year":"2022","journal-title":"Nature Microbiology 2022 7:12"},{"key":"2026041023375454000_2025.02.03.636326v2.47","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.5jyl8xn69v2w\/v1"},{"key":"2026041023375454000_2025.02.03.636326v2.48","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-016-0218-6"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.03.636326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:38:07Z","timestamp":1775889487000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.02.03.636326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1101\/2025.02.03.636326","relation":{},"subject":[],"published":{"date-parts":[[2025,2,3]]},"subtype":"preprint"}}